Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dr Reddy’s Charts Sharp Cost Overhaul Amid Weak Q1

Pharma pills

Related Content

Dr. Reddy’s Warns US Market ‘Unpredictable’ As Q4 Profit Below Expectations

May 16 2017

Manufacturing Woes Continue To Plague Dr Reddy’s; Are Generic Gleevec Launch Plans Under Threat?

Mar 09 2017

Related Companies

Dr. Reddy's Laboratories Ltd.

Additional Topics

India Asia Pacific Sales & Earnings Generic Drugs Companies Commercial BioPharmaceutical

More from Earnings

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window